FiercePharmaOriginal article
{"a":[{"_":"Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue","$":{"href":"/manufacturing/dr-reddys-presses-pause-generic-semaglutide-supply-after-flagging-api-issue","hreflang":"en"}}]}
negativegeneric semaglutideNegative
AI Analysis
Summary
Dr. Reddy's has paused production of generic semaglutide due to an active pharmaceutical ingredient (API) issue, potentially impacting supply of this high-demand generic drug.
Outcome Details
Manufacturing pause due to API issue flagged
Importance:5/10
Sentiment:
-0.70
manufacturinggeneric drugsupply chainAPI issuesemaglutide
Related Companies
Read the original article
Published by FiercePharma on July 9, 2026 8:38 AM